Potential Microcap Multibagger:
π Orderbook: βΉ2000+ Crores
π [ Mega Thread ] π§΅
Techno-Funda Analysis π
π Orderbook: βΉ2000+ Crores
π [ Mega Thread ] π§΅
Techno-Funda Analysis π
(2) Sector outlook:
- In 2020, Indiaβs share of the global EMS market was about 2.2% (USD 20 billion), but itβs expected to grow at 32% CAGR from 2021 to 2026.
- India's medical devices market is worth $11 billion today and is set to reach $50 billion, growing at a rate of 15% each year.
- Demand for medical devices in India is much higher than the supply, giving domestic manufacturers a chance to fill the gap.
- In 2020, Indiaβs share of the global EMS market was about 2.2% (USD 20 billion), but itβs expected to grow at 32% CAGR from 2021 to 2026.
- India's medical devices market is worth $11 billion today and is set to reach $50 billion, growing at a rate of 15% each year.
- Demand for medical devices in India is much higher than the supply, giving domestic manufacturers a chance to fill the gap.
- βΉ3,420 crore has been allocated by the Indian government for the medical devices industry under the PLI scheme, from 2020-21 to 2027-28.
- Defense and aerospace sector in India is expected to increase from USD 27.1 billion in 2024 to USD 54.4 billion by 2033, growing at 6.99% annually.
- Defense and aerospace sector in India is expected to increase from USD 27.1 billion in 2024 to USD 54.4 billion by 2033, growing at 6.99% annually.
(3) Vinyas Innovative Technologies Limited's revenue segments for the fiscal year 2024:
- Aerospace and Defence: 84.73%
- Medical: 1.71%
- Others (Industrial, Telecommunications, Automotive & Consumer segments): 13.56%
- Aerospace and Defence: 84.73%
- Medical: 1.71%
- Others (Industrial, Telecommunications, Automotive & Consumer segments): 13.56%
(4) Company management's outlook:
- Vinyas expects its revenue to grow consistently by 20-25% in the coming years.
- Strong order pipeline for the next five to six years supports the company's growth potential.
- Company expects more orders, especially as defense and aerospace projects move from the testing stage to full production.
- Vinyas expects its revenue to grow consistently by 20-25% in the coming years.
- Strong order pipeline for the next five to six years supports the company's growth potential.
- Company expects more orders, especially as defense and aerospace projects move from the testing stage to full production.
(6) Financial Metrics:
β CMP: 917
β Mcap: 1,154 crores
β Orderbook: 2000+ Cr. vs current sales at 329 Cr.
β TTM PE: 69
β Forward PE: 41
β ROCE: 20%
β ROE: 17.6%
β D/E Ratio: 0.69
β Current ratio: 1.52
β OPM: 11%
β NPM: 5%
β Promoter holdings: 29.4%
β 3 years sales, profit growth: 16% and 120%
β CMP: 917
β Mcap: 1,154 crores
β Orderbook: 2000+ Cr. vs current sales at 329 Cr.
β TTM PE: 69
β Forward PE: 41
β ROCE: 20%
β ROE: 17.6%
β D/E Ratio: 0.69
β Current ratio: 1.52
β OPM: 11%
β NPM: 5%
β Promoter holdings: 29.4%
β 3 years sales, profit growth: 16% and 120%
(7) Chart overview:
Breakout occurred on the daily chart as the stock moved above resistance after touching the trendline, indicating a possible rally. x.com
Breakout occurred on the daily chart as the stock moved above resistance after touching the trendline, indicating a possible rally. x.com
If you found this useful:
(1) Follow me @rohaninvestor for more such threads.
(2) Bookmark this thread for future.
x.com
(1) Follow me @rohaninvestor for more such threads.
(2) Bookmark this thread for future.
x.com
Loading suggestions...